Skip to main content
Publications
Mazurek M, Halperin JL, Huisman MV, Diener HC, Dubner SJ, Ma CS, Rothman KJ, Healey JS, Teutsch C, Paquette M, Franca LR, Lu S, Bartels DB, Lip GYH. Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme. Europace. 2020 Jan 1;22(1):47-57. doi: 10.1093/europace/euz278
Huisman MV, Ma CS, Diener HC, Dubner SJ, Halperin JL, Rothman KJ, Teutsch C, Schoof N, Kleine E, Bartels DB, Lip GY. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) phase I cohort. Europace. 2016 Sep;18(9):1308-18. doi: 10.1093/europace/euw073
Payne JR, Eleftheriou KI, James LE, Hawe E, Mann J, Stronge A, Kotwinski P, World M, Humphries SE, Pennell DJ, Montgomery HE. Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart. Heart. 2006;92(12):1784-8.
Palka P, Lange A, Fleming AD, Starkey IR, Fenn LN, Shaw TRD, Fox KAA, McDicken WN, Sutherland GR. Transmural velocity gradients-A new ultrasonic index for hypertrophic cardiomyopathy hearts. Poster presented at the British Cardiac Society Annual Meeting; May 7, 1996. Glasgow, Scotland. [abstract] Heart. 1996 May 1; 75(5 Suppl 1):21. doi: 10.1136/hrt.75.5_Suppl_1.P6